ArticleHepatology communications2017

Concomitant proton pump inhibitor use does not reduce the efficacy of elbasvir/grazoprevir: A pooled analysis of 1,322 patients with hepatitis C infection.

Nancy Reau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.